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also positive for C. pneumoniae antigens. Cells positive for C. 
pneunioniae colocalized in adjacent sections with TUNEL-positive 
cells, suggesting that the fragmented DNA could originate from C. 
przmmoniae 
Conclusions: C. prieumoniae 16s rRNA and DNA are not detect- 
able in advanced atherosclerotic lesions. C. pnenmoiiiae DNA might 
be heavily degraded. C .  prieumoniae antigens persist in macrophages, 
but not viable bacteria. 
ml Chlamydia pneumoniae infection induces the 
development of antibodies to HSPGO in rabbits 
T. Huittinen, P. Saikku, M. Leinonen. National Public Health 
Institare, Oulu, Finland 
Objectives: Chlamydia pneumortiae infection is associated with 
arteriosclerosis. Intranasally inoculated C. pneunioniae has been shown 
to induce inflammatory arteriosclerosis-like changes in the aortas of 
rabbits by 5 weeks after infection and its presence in produced lesions 
has been demonstrated. Several reports have demonstrated the 
involvement of C, trarliomatis HSP60 proteins in tissue damage after 
repeated infections. Our purpose was to measure C. pneumoniae 
HSP60 antibodies in the sera collected from rabbits infected intra- 
nasally with C. ptieuwiotirae to see whether these antibodies are formed 
in response to infection and if their presence correlates with the 
inflaniinatory findings in rabbit aortas 
Methods: The sera of 22 New Zealand White rabbits infected 
twice intranasally with C. pneumotiiae were tested by enzyme 
imniunoassay for the presence of C. pneumorziae HSP60 and 
hfyrobucterinm botir HSP65 antibodies 
ResuIts: HSP60 antibodies increased as a function of time up to 
the fifth week from infection. Samples from uninfected animals did 
not contain antibodies against the HSP60 proteins. All infected 
animals had high antibody titers at the end of the experiment, when 
six of nine rabbits had developed arteriosclerotic changes. There was 
a significant correlation (0.79) between C. pneumnniae HSP6O and 
hf. bovis HSP65 antibody titers. Thus, intranasal infection with C. 
pneunioniae had led to the development of cross-reactive i\f. bovis 
HSP65 antibodies in addition to specific antibodies 
Conclusions: C. pneumotriae HSP60 antibodies were formed in 
rabbits infected with C. pneurnoniae simultaneously with the develop- 
ment of arteriosclerotic changes in aortas, and these animals showed 
cross-reactive responses to HSP60 protein, suggesting the possibility 
of an autoimmune reaction as well. Further studies are needed to 
resolve the role of HSP60 proteins in the pathogenesis of arterio- 
sclero\is 
I 064 1 Assessment of regional cerebral blood flow in 
patients with bacterial meningitis by dynamic 
computed tomography 
A. Garlicki', B. Podtiadlo-Kleinrok', K. Kleinrok', 
M. Bociaga-Jasik', B. Toniik' , J. Krukowiecki'. Departments .f 
'hficfious Disenres, 'Radiology and -'Neurology '$the Cu[legiuni 
Aledicuin Jaxiellonian Uriiversity, Cracon: Poland 
The aim ofthe study was to determine correlations between changes 
in cerebral blood flow in patients with bacterial meningitis and 
neurologic symptoms, severity of the disease assessed on the basis of 
the Glasgow Coma Scale (GCS), pleocytosis and protein concen- 
tration in cerebrospinal fluid (CSF). Dynamic CT, which consists of 
doing rapid scans of the same layer after administration of iodic 
contrast, was done in 34 patients with bacterial meningitis. The 
regional blood supplied was assesed by measurement of medium 
value of radiation attenuation coefticient in the white matter of 
frontal and occipital horns of lateral ventricles, syimnetrically in both 
hemispheres. Dynamic C T  was done 3-4 days after the onset of 
symptoms and was repeated after 6-8 weeks. Differentiation in the 
regional blood flow during the acute phase of the disease was 
observed. Reduction of the regional perfusion in the acute phase 
compared to the convalescent phase of the diwase was demonstrated. 
In both the acute and convalescent phases, perfusion was higher in 
the posterior part of the brain. In some patients, a relationship 
between the appearance of neurologic symptoms (seizures. pyramidal 
syndrome, cranial and peripheral nerve palsies) and changes in blood 
flow in particular regions of the brain was noticed. In patients who 
aggregated low GCS scores, inflow of the blood w3s high, and in 
patients who were in better condition, inflow was snialler. High 
pleocytotis in the CSF was associated with small blood inflow and 
perfusion, whereas high protein concentration correlated with higher 
inflow and increase in regional perfusion 
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wl Performance of the Becton Dickinson 
BDProbeTec ET System in detecting Chlamydia 
trachomatis and Neisseria gonorrhoeae from 
endocervical and urine specimens in women 
D.V. Ferrero', L. Buck-Barrington'. H.  Meyers', S. Willic. 'Dhcose 
Coiztrnl and Prevoition Division, 'Regional Pirblic Health Lahoratouy, 
SanJbaquin County Public Healtli Services, Storktoon, C 4 ,  I :S.4 
Objective: To evaluate the performance of the UDProbcTec ET 
System for the detection of Chlamydia trachanintis and Nfisserin 
yonorrlioear in women having a low prevalence of infection 
Method: Endocervical and urine specimens were obtained from 
507 female patients attending family planning clinics. Each 9pecimen 
was tested using the BDProbeTec ET System, conventional culture 
techniques, and LCR technology for the presence of C. traclioniatis 
and N. pnurrhoeae. BDProbeTec ET System performance wat com- 
pared to an 'enhanced' gold standard. The 'enhanced' gold standard 
is defined as a laboratory diagnosis of infection based upon the 
combined criteria of culture, another nucleic acid amplification test 
(LCR), and direct fluorescent antibody 
Results: The sensitivity of the BDProbeTec ET System C. 
tradio~natis assay for endocervical swab specimens was 95.5'%, with a 
specificity of 99.1%, and for urine specimens the tensitivity was 
10096, with a specificity of98.4%. The sensitivity ofthe BIlPrnbeTec 
ET System N pmirriioenc assay for endocervical swab specimens was 
100%. with a specificity of 99.6%, and for urine specimens the 
sensitivity was 80.0%. with a specificity of 99.2% 
Conclusion: The BDProbeTec ET System is a highly tcnsitive 
and specific DNA amplification assay for the detection nt'chlaniydial 
and gonorrheal infections in women for both endocervical and urine 
specimens. 
vl Comparative evaluation of three commercial 
quantitative HBV DNA assays 
I. Marin, M. Poljak, K. Seme, S. Koren. kstitute ujhlirrobiolo,q~~): 
Medical Faculty, Ljrrbljana, Sloiwia 
Objectives: In the present study we cornparativrrly evaluated three 
commercially available assays for quantification of hepatitis B virus 
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(HBV) DNA in serum samples: branched DNA (bDNA) assay 
(Quantiplex, Chiron), hybridization-capture assay (Digene Hybrid- 
Capture, Murex) and quantitative PCR assay (Amplicor HBV 
Monitor, Roche) 
Methods: Sixty-seven unselected consecutive serum samples with 
a request for HBV DNA quantification were analyzed. Among them, 
41 serum samples were tested by Amplicor and bDNA assays, 43 
samples by hybrid capture and bDNA assays and 45 samples by hybrid 
capture and Amplicor assays. Thirty-eight serum samples were tested 
using all three assays 
Results: Amplicor and bDNA assays gave concordant results in 37 
of 41 [90%) samples (all HBV DNA positive), hybrid capture and 
bDNA assays in 33 of 43 (77%) samples (29 HBV DNA positive and 
four negative), and hybrid capture and Amplicor in 34 of 45 (76%) 
samples (all HBV DNA positive). The sensitivities of the hybrid 
capture, bDNA and Amplicor assays, as determined in the com- 
parative study on the 38 samples, were 71%. 89% and loo%, 
respectively. Among the assays compared, the correlation was highest 
between the hybrid capture and Amplicor assays (r=0.61,p=0.0001), 
moderate between the hybrid capture and bDNA assays ( ~ 0 . 4 7 ,  
p=0.011), and lowest between the Amplicor and bDNA assays 
( ~ 0 . 3 0 ,  p=0.069) 
Conclusion: According to the results of our study, the Amplicor 
HBV Monitor seems to be the most sensitive commercial assay for 
quantitative measurement of HBV DNA in serum samples 
F I  Performance of the BDProbeTec(TM) ET CT/GC 
System 
N. Jensen, J. Wood, D. Wolfe, P. Johnson, M. Kuhn, D. Shank, 
V. Aharam, C. Dulany, Y. Do, M. Boenisch. Becton Dickinson 
Microbiology Syjlems, Sparks, MD, USA 
Objectives: The performance of the BDProbeTec ET system for 
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) detection 
was determined by several analytic studies designed to identify the 
sensitivity, specificity and specimen storage stability of the system 
Methods: Analytic sensitivity for both the C T  and GC assays was 
determined by testing dilutions of a variety of C T  (n=15) and GC 
(n=7) isolates. Potential cross-reactants were identified by assaying 
samples containing cells or DNA from different microorganisms 
(n=84), including bacteria, yeasts, and viruses. Specimens (urine, 
male and female swabs) containing C T  and GC were stored a t  2-8OC, 
2153-C and 27?3'C for up to 6 days, and then processed and 
assayed for C T  and GC to determine stability 
Results: The BDProbeTec ET C T  and GC assays detected 57 
elementary bodies per test, and 4 cells per test, respectively. Neither 
assay cross-reacted with any of the microorganisms tested. Urine 
samples containing CT, and male or female swabs containing C T  or 
GC, were stable for up to 6 days at all temperatures. Urine samples 
containing GC were stable at 2-8°C for 6 days, 21°C for 5 days, and 
27OC for 3 days 
Conclusions: The BDProbeTec ET system provides sensitive and 
specific detection of C T  and GC. Specimens collected for assay in 
the system can be stored refrigerated or at room temperature for up 
to 6 days, except for room temperature urine samples to be tested for 
GC, which are stable for 3 days. 
ml Optimized serum sample treatment and use of 
an internal mimic for the detection of 
PCR-amplified parvovirus B 19 DNA 
M. Zerbini, G. Gallinella, E. Manaresi, M. Musiani, G. Gentilomi, 
S. Venturoli. Department UJ Clinical Experimental Medicine, 
Microbiology, Univerrity of Bologna, Italy 
Since its discovery in healthy blood donors, B19 parvovirus has been 
associated with an increasing range of clinical manifestations. The 
diagnosis of active B19 infection is based on the detection of B19 
DNA sequences in clinical samples, since B19 parvovirus does not 
grow efficiently in continuous cell cultures. Several techniques have 
been developed to detect B 19 DNA, and home-made PCR assays 
are especially used for their high sensitivity in diagnostic laboratories 
We evaluated three different sample treatments, on the basis of the 
efficiency of recovery, reproducibility, convenience of sample hand- 
ling and presence of PCR inhibitors to standardize a PCR assay in 
serum samples for the detection ofparvovirus B 19 DNA. Moreover, 
the presence of an internal standard competitor as the working 
reagent at one defined concentration in a competitive PCR-ELISA 
has been proposed as a valid tool to standardize and validate the assay. 
Our results indicate that serum sample treatment by quick heating 
fulfills the criteria for a routine practice in the diagnostic laboratory. 
Titration experiments performed to define the optimal amount of 
the internal standard competitor to use in PCR-ELISA showed that 
at 2X 10' genome copies, any amplification interferences between 
target and competitor sequences were avoided. The internal standard 
competitor in a competitive PCR-ELISA allows the detection of 
false-negative results due to PCR inhibitors in the samples or great 
amounts of target DNA. Heating treatment and competitive PCR- 
ELISA was applied to the analysis of 347 serum samples for the 
detection of parvovirus B 19 DNA 
w] New technologies for quantitation of HCMV 
DNA in plasma and PBLs and for detection of 
pp67 RNA in whole blood from renal 
transplant recipients (RTRs) 
I. Pellegrin, P. Merel, I? Merville, I. Garrigue, M.H. Schrive, 
M.E. Lafon, V. Dubois, F! Trimoulet, H.J.A. Fleury. Chu pellegrin, 
Laboratoire de virolqie, Bordeaux, France 
Detection of active human cytomegalovirus [HCMV) infection after 
renal transplantation is needed to initiate pre-eniptive anti-CMV 
therapy. The aim of the study was to define the most valuable 
molecular assay in terms ofsensitivity, specificity, VPP and VPN. The 
final goal was the replacement of time-consuming pp65 antigenemia 
(pp65Ag). Thirty RTRs were enrolled during the first week follow- 
ing transplantation and were followed every week for 3 months. 
Plasma, PBLs and whole blood were collected for pp65Ag, 
AMPLICOR CMV (P-AMP, Roche), AMPLICOR CMV 
MONITOR (CMM, Roche), bDNA CMV 2.0 (Chiron) and 
Nuclisens CMV pp67 (Organon Teknika) 
Twelve patients remained CMV infection free during the follow- 
up period. CMV infection (defined by (+) pp65Ag) occurred in 18 
subjects, and five of 18 developed a CMV disease (one pneumonia, 
four hypertherniia+hepatitis cytolysis). Among the 12 patients 
without (+) pp65 Ag (median=samples/patient), only two patients 
showed a single (+) result with bDNA CMV 2.0. All the results 
obtained with other assays were negative 
All patients were treated with ganciclovir from the first (+) pp65 
antigeneniia. All the 18 subjects who developed CMV infection 
exhibited several positive bDNA CMV 2.0 results during their 
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follow-up, whereas only eight of1 8 and seven of 18  showed Nuclisens 
CMV pp67 and P-AMP/CMM positive results, respectively 
These discordances between molecular assays niay reflect singular 
HCMV kinetics in these diifrrent blood compartments. Statistical 
analysis is underway and will help us to choose the most appropriate 
molecular method for CMV disease diagnosis and follow-up under 
treatment. 
Development of a diagnostic strategy to 
monitor CMV in transplant patients 
M. leven, H. Janrens, D. Ursi, D. Provinciae, W. Goossens, 
J.L. Bosnians, G. Verpooten, H. Goossens. University Hospital 
&4 ti tir wp, h firrohiolugy, Ede~qtw, Be@ntn 
Objectives: ( I )  To evaluate the sensitivity and specificity of (a) a 
CMV quantitative hybrid capture system (HCS) in leukocytes, (b) 
pp65 antigen detection by imniunofluorescence and (c) CMV 
polymerase chain reaction (PCR) on  plasma compared with CMV 
P C R  on leukocytes, and ( 2 )  to develop a valuable diagnostic strategy 
Methods: Four hundred and twenry-two blood specimens from 
27 kidney and seven heart transplant patients were tested. Patients 
were followed weekly for 3 months after transplantation 
Results: HCS and pp65 had sensitivities of 40.8% and 57.4% 
respectively when compared with P C R  on leukocytes. Both were 
highly specific: 100% and 98.5% respectively An 82.7% and 83.1% 
concordance was observed between the pp65 test and the P C R  on 
leukocytes and on  plasma respectively Most of the discordant tests 
resulted from the high sensitivity of the P C R  during the early and 
late phases post-transplantation. Extrapolating from these, discord- 
ance rates between the pp65 antigen test and P C R  on leukocytes and 
plasma are only 4.5%) and 5.1% respectively Concordance between 
HCS and PCK on leukocytes was 78.0%. When compared with the 
pp05 antigen test, the sensitivity of the HCS was 54.2%; 87.0% of 
the HCS tests were concordant with the pp65 antigen results. The 
lower sensitivity of the HCS is related to cpecimens with a low 
number of pph5-positive cells ( < Z O / l O h  cells ). Specimens became 
positive by P C R  on  average 3.8 weeks after transplantation and 
remained PCR positive for a mean of 8.8 weeks. On  average, PCR 
was positive 1.5 weeks earlier than the pp65 test and, on average, 
remained positive for 1.4 weeks longer. In 42.1% of the cases, P C R  
on leukocytes was positive 1 week earlier than P C R  on  plasma. In 
47.4% of the cases, P C R  on leukocytes and on  plasma became 
positive at the saiiie iiionient 
Conclusions: A valuable diagnostic strategy could be to follow 
iiiiiiiuiiocoii~proiiiise~ patients by a CMV-PCR either on leukocytes 
or 011 plasma aiid to apply the quantitative pp65 antigen test as soon 
as the PCR becomes positive. 
(1 Application of the NucliSens Basic Kit to 
detection of enterovirus RNA 
S. H m ' ,  D. Westmoreland', J.D. Fox'. ' I  TLt'CAf, -'UHIZ: G7rdjg 
UK 
Objective: Molecular methods based on NASUA have well-recog- 
nized advantages over RT-PCR for amplification atid detection of 
R N A  targets. The aim of this study was to devrlop and evaluate an 
enterovirur-specific NASBA method ruitable for ure in a diagnostic 
laboratory 
Methods: Primers and probes were designed for detcction of a 
wide range of sequenced enteroviruser. For 'boom' extraction of 
nucleic acid, NASBA and electrochemiluminescence detection we 
used the NucliSens Ba$c Kit (Organon Teknika Ltd). Thic i\  a coiii- 
plete kit for developing home-made R N A  amplific~ation asrayc for 
diagnostic use. The  new arsay was compared with current in-house 
molecular methods (semi-nested RT-PCR and NASUA) and culture- 
based procedures for analysis of stool raniples and control viruses 
( n = l l 3 )  
Results: The NucliSens Basic Kit assay was niore smjitive than 
culture for identification of enteroviruses in stool s:imples. The assay 
gave comparable results to well-evaluated molecular methods utiliz- 
ing in-house reagents on a wide range ofenterovirus types 
Conc1usions:Use of the NucliSens Basic Kit reagents enabled the 
simple development of an enterovirus-specific NASBA qplic,iblr to 
a wide range of clinical samples (particulxly stool m d  cerebrorpinal 
fluid). Coniniercially available reagentr for the development of 
flexible NASBA protocols (with primers and probes designed by the 
user) will enable this method to be utilized widely in diagiioctic and 
research laboratorio 
ml Detection of M. pneumoniae by Nuclisens 
Basic Kit 
K. Loeiis, M. Leven, D. Ursi, H. Foolen, I-! Sillckens, H. Goossens. 
Unitwsi fy  iff.4ntrrwp, hLd icd  Microbiology, It 'ilryk, Bc[qiirrti 
Objectives: To evaluate the Nuclisens Basic Kit (Organon Teknika) 
for the detection of Afycoplasnza pricuniorriac in respiratory specimens, 
and to evaluate the quality of the Basic Kit reagents and the 
information provided by the package insert 
Methods: Modification of existing ,if. pncirnioiriae 1 hS r l iNA 
primers and probes to be used in the Basic Kit format; evaluation of 
the analytic sensitivity of the Basic Kit-based ,ZI. pticirnioniac 16s 
rRNA primers by comparison with standard M .  p ~ r c i ~ t ~ i c ~ ~ i i a c  16s 
rRNA nucleic acid sequence-based amplification (NASBA) pruners 
through testing of dilution panels; evaluatioii of Haw Kit-hated 
ECL-detection of hf. pr7cumunine 1 hS rRNA NASBA aniplicon~ and 
comparison to standard ECL detectlon of these aiiipliconr; ev.iluation 
of the Basic Kit Positive Control in respiratory specimens; .Inalyris of 
clinical respiratory specimeiis 
Results: Optimal specificity is obtained by using the standard 
primers and probes, and by using the Basic Kit primers in 
combination with the Basic Kit ECL probe and a newly developed 
capture probe. The use of different primer and probe combinations 
for respiratory specimens doer not influence the sensitivity. The  
detection level was 25 cells in all cases. The positive control, provided 
in the Basic Kit, was detected easily. Non-rpecific amplification uring 
the positive control primers and probes occurred \eldoiii and mainly 
in sputum specimens 
Conclusion: Thew results show that the quality of the Nuclisens 
Basic Kit and the user-friendliness of the assay are satisfactory. Thus, 
this kit could become J. useful tool in the diagnostic laboratory 
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ml Identification of Nocardia genus by PCR 
F. Laurent',', P. Boiron'. Instirut Pasteirr, LJrLit q f A 4 y c o l o ~ f ~  Paris, 
'Lab07dtor)J of BactCriology, Hospices Civils de Lyon, Lyon, France 
The conventional identification of strains belonging to actinoniycetes 
is based on chemotaxonoinic characteristics. However, these tech- 
niques are laborious, time-consuming, and expensive; they can take 
1-3 weeks to accomplish and are sometimes not able to fully differen- 
tiate some of the most closely related strains. Two regions of the gene 
coding for 16s rKNA in Norardia species were selected as genus- 
specific primer sequences for a P C R  assay. The PCR protocol was 
tested with 60 strains of clinically relevant Nocardia isolates and type 
strains. It gave positive results for all strains tested. Conversely, the 
PCR assay was negative for all tested species (n=70) belonging to the 
most closely related genera, including Dietzia, Gordona, Myco- 
bacterium, Rhodococcus, Streptomyces, and Tsukamurella. Besides, unlike 
the latter group of isolates, all Nocardia strains exhibited one MInI 
recognition site but no Sad restriction site. This assay offers a novel 
specific and rapid (less than 2 days) alternative to chemotaxonomic 
methods for identification of Nocardia spp. isolated from pathogenic 
samples. It would improve the speed of diagnosis, which is closely 
related to the favorable evolution of the patienti condition (mortality, 
relapses and after-effects). At present, we are performing an extensive 
study of the use of this PCK technique directly with clinical samples. 
Rapid detection of toxigenic Clostridium 
difficile from stool samples by a nested PCR of 
toxin B gene 
R. Alonso, C. Munoz, S. Gross, D. Garcia de Viednia, T. Pelaez, 
M. Rodriguez-Creixems, E. Bouza, Hospital Greprio Maranon, 
Microbiolgia, Madrid, Spaitr 
Introduction: Toxigenic Clostridium dijficile is the etiologic cause of 
most cases of antibiotic-associated diarrhea. The present standard 
method for C. d@ri/e detection is a cytotoxicity assay performed on 
human fibroblasts which is time-consuming and requires special 
facilities 
Objective: To develop a nested P C R  assay for the detection of 
toxigenic strains of C. d@ci/e directly from clinical stool samples 
Materials and methods: One hundred and two stool samples, 
submitted to our laboratory for C. dlfFn'/e investigation, were in- 
cluded. All samples were cultured on CCFA, toxicity was tested on 
fibroblasts and all were processed by PCR. Samples were prepared for 
PCR following a commercial extraction system (QIAmp Tissue Kit, 
QIAGEN, USA). Primers CDTBI (GTG GCC CTG AAG CAT 
ATG), CDTB? (TCC TCT C T C  TGA ACT T C T  TGC) and 
CDTB3 (GCT TCT TCA ATC C T T  T C C  TC) were used for 
amplifications. All samples included an internal control to check for 
potential inhibitions 
Results: Twenty-seven samples (26.5%) carried toxigenic C. 
d$ficik strains, while the remaining 75 (73.5%) did not carry the 
microorganism. The agreement between cytotoxicity and the P C R  
assay was 99% Sensitivity, specificity, and positive and negative 
predictive values of the PCR versus cytotoxicity assay were 96.3%, 
100%. 100% and 98.7% respectively. Inhibition was observed in 0.9% 
of the samples. The procedure is fast (about 4 h), easy to perform and 
correlates very well with the present reference method 
Conclusions: Direct PCR may be an option for detecting C. 
d@ci/e directly from stool samples, especially for laboratories lacking 
tissue-culture facilities 
Methicillin-resistant Staphylococcus aureus 
(MRSA)/Vancomycin-resistant enterococci 
(VRE) 
ml In vivo horizontal transfer of the mecA 
determinant conferring methicillin resistance 
C.L.C. Wielders, E.D.J. Peeters, A.T.A. Box, C.A.M. Miltenburg, 
A. Troelstra, A. Fleer, F.J. Schmitz, J.Verhoef, A.C. Fluit. 
Eijkman- CVirzkler Institute, University Hosp. Utrecht, The  Netherlands 
Introduction: The use of oxacillin results in ongoing selection for 
methicillin-resistant Staphylococcus aimus (MRSA) strains. Here we 
report evidence for the in vivo transfer of the mccA determinant, 
which is implicated in rnethicillin resistance, to S. aureirs 
Results: Afcer 3 weeks of antibiotic therapy to treat an initial 
(non-MRSA) staphylococcal infection, an MRSA-positive blood 
sample was obtained from a neonate carrying an infected thorax 
canula. These successive infective isolates shared an uncommon 
phage type. Comparison of Smal-generated restriction fragment 
length (PFGE) patterns revealed a single bandshift, resulting from 
incorporation of a 40-kb fragment that hybridized with a niecA probe. 
This indicates that horizontal transfer of the mecA DNA that confers 
resistance to niethicillin did occur in the presence of selective anti- 
biotic pressure in vivo. Several mecA+ coagulase-negative staphylo- 
coccal species could be isolated from the child as a potential source 
for the merA DNA. In addition, an MSSA producing a 6-lactamase 
with a phage and PFGE type identical to those of the initial MSA 
isolate could be cultured. --Lactamase-carrying plasmids are impli- 
cated in the stability and expression of the mecA region. From the 
father of the neonate, a non---lactamase-producing MSSA strain of 
matching genotype was isolated 
Conclusion: These data suggest the evolution from --lactamase- 
negative MSSA, through -4actamase-producing MSSA, to MRSA 
in vivo 
Spread of methicillin-resistant clumping factor- 
negative (CF-) Staphylococcus aureus 
K. Trzcinski, J. Walory, S. Murchan, W. Hryniewicz. Sera and 
I'accines Central Rescarch Laboratory, CZ.hrsaw, Poland 
Objectives: To investigate the relatedness of 30 MRSA isolates from 
Poland, Hungary and Slovenia, identified as clumping factor negative 
(CF-) 
Methods: Identification of S. a~ueus was based on detection of 
free coagulase by tube test and precence of coagulase (coa) and protein 
A (spa) genes detected by PCR.  Relatedness among MRSA strains 
was evaluated by restriction fragment length polymorphism (RFLP) 
analysis of spa and coa genes, arbitrary primed (AP) PCR analysis of 
total DNA with AP-7 primer, and RFLP analysis of SmaI-digested 
chromosomal DNA following PFGE. Antimicrobial resistance 
patterns were evaluated using a set of 20 antimicrobial agents 
Results: All strains were CF- by slide agglutination test with rabbit 
plasma. Analysis of coa and SmaI RFLP revealed identical coo and 
closely related StnaI patterns for 17 of the 30 MRSA isolates from 
Hungary, Poland and Slovenia (cluster I ) .  Spa gene polymorphism 
analysis showed that all these isolates carried 10 or I 1  repetitive 
motifi. Only three isolates originating from a single center in Poland 
showed a different genotype clearly identified by roa and S n d  RFLP 
patterns (cluster 11). Almost all 27 genetically related isolates of cluster 
I showed similar patterns of resistance to ammoglycosldec, macro- 
lides, lincosamides, tetracyclines, rifampin and ciprofloxacin, whereas 
